Latest Rochester Medical Center Stories
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly
A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease.
A new study shows that a neurologist in an office thousands of miles away can deliver effective specialized care to people with Parkinson's disease.
A team from the University of Rochester Medical Center has shown scientifically what many women report anecdotally: that the breast cancer drug tamoxifen is toxic to cells of the brain and central nervous system, producing mental fogginess similar to "chemo brain."
A new study claims there is no association between prenatal mercury exposure and autism-like behaviors. Their findings were published online in the journal Epidemiology and draw upon more than 30 years of research in the Republic of Seychelles.
Patients in moderate to severe pain in emergency rooms across the U.S. are less likely to receive opioid pain medications if they are black, Hispanic, poor, or have less education, compared to more affluent patients.
Scientists are scrambling to gather data for the FDA to support the need for a blood test to diagnose brain injury in the United States.
Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen’s secondary activities so that it might work on more aggressive breast cancer.
A group of non-neural cells found in the human central nervous system may be more essential to the complexity of our brains than previously believed, according to new research published Thursday.
- a slit in a tire to drain away surface water and improve traction.